APA (7th ed.) Citation

Y, S., L, F., M, Z., J, B., D, M., B, S., . . . B, P. (2019). The LPS/D-Galactosamine-Induced Fulminant Hepatitis Model to Assess the Role of Ligand-Activated Nuclear Receptors on the NLRP3 Inflammasome Pathway In Vivo. Methods in molecular biology (Clifton, N.J.), 1951, 189. https://doi.org/10.1007/978-1-4939-9130-3_15

Chicago Style (17th ed.) Citation

Y, Sebti, Ferri L, Zecchin M, Beauchamp J, Mogilenko D, Staels B, Duez H, and Pourcet B. "The LPS/D-Galactosamine-Induced Fulminant Hepatitis Model to Assess the Role of Ligand-Activated Nuclear Receptors on the NLRP3 Inflammasome Pathway In Vivo." Methods in Molecular Biology (Clifton, N.J.) 1951 (2019): 189. https://doi.org/10.1007/978-1-4939-9130-3_15.

MLA (9th ed.) Citation

Y, Sebti, et al. "The LPS/D-Galactosamine-Induced Fulminant Hepatitis Model to Assess the Role of Ligand-Activated Nuclear Receptors on the NLRP3 Inflammasome Pathway In Vivo." Methods in Molecular Biology (Clifton, N.J.), vol. 1951, 2019, p. 189, https://doi.org/10.1007/978-1-4939-9130-3_15.